Product Information
PHENOBARBITAL 30 MG TABLET is a generic product labeled by Westminster Pharmaceuticals LLC, priced at $0.1284 per EA under NDC 69367069201. Its NADAC has been published 137 times since Nov 15, 2023.
Strength
30 mg/1
Manufacturer
Westminster Pharmaceuticals LLCNDC
69367069201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PHENOBARBITALApproval Type
Unapproved
On Market Since
9/8/2023
Price Statistics
The NADAC for PHENOBARBITAL 30 MG TABLET has been published 137 times since Nov 15, 2023, and over the history we have for it it has declined 10.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1284 per EA |
|---|---|
| All-time high | $0.1847 (Apr 10, 2024) |
| All-time low | $0.0913 (Nov 20, 2024) |
| 52-week high | $0.1735 |
| 52-week low | $0.1284 |
| Median price | $0.1538 |
| Average price | $0.1496 |
| Largest weekly change | -45.1% (Nov 20, 2024) |
| Weeks tracked | 137 |
| Tracking since | Nov 15, 2023 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PHENOBARBITAL 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PHENOBARBITAL 30 MG TABLET, manufactured by Westminster Pharmaceuticals LLC, is $0.1284 per EA (NDC 69367069201), effective Jun 24, 2026.
How has the price of PHENOBARBITAL 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for PHENOBARBITAL 30 MG TABLET has declined 10.5%. It has been tracked across 137 weekly CMS publications since Nov 15, 2023.
What are the highest and lowest recorded NADAC prices for PHENOBARBITAL 30 MG TABLET?
Since Nov 15, 2023, the NADAC for PHENOBARBITAL 30 MG TABLET has ranged from a low of $0.0913 (Nov 20, 2024) to a high of $0.1847 (Apr 10, 2024), with a median of $0.1538 per EA.
Are there cheaper alternatives to PHENOBARBITAL 30 MG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as PHENOBARBITAL 30 MG TABLET, but none are currently priced below it.
Who manufactures PHENOBARBITAL 30 MG TABLET?
PHENOBARBITAL 30 MG TABLET (NDC 69367069201) is labeled by Westminster Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification